Welchol Added To AACE Diabetes Guideline
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo announced that Type II diabetes and high cholesterol drug Welchol (colesevelam) has been added to the Road Maps to Achieve Glycemic Control in Type 2 Diabetes Mullitus, a guideline used by physicians and published by the American Association of Clinical Endocrinologists. The company estimates the addition will result in expanded use of the drug. (Click here for more-Japanese language